Ehret, F., F. B. Abid, V. T. Ribeiro, R. Bodden, F. C. Maluf, P. Larco-Castilla, L. M. Naud, C. Ferraz de Paula Soares, E. Shaikh, L. Valente de Camargo, and F. M. Ridolfi. “The IDEAL Trial - a Study Protocol for a Phase III Randomized, Double-Blinded Clinical Trial Assessing the Ultra-Short Antibiotic Prophylaxis of Isoniazid and Rifapentine in Non-Immunosuppressed Patients With Newly Diagnosed Latent Tuberculosis”. Principles and Practice of Clinical Research, vol. 6, no. 1, May 2020, pp. 9-14, https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/96.